Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$9.77 - $15.33 $1.95 Million - $3.07 Million
-200,000 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$10.51 - $17.46 $2.1 Million - $3.49 Million
200,000 New
200,000 $3.03 Million
Q3 2018

Nov 13, 2018

SELL
$13.94 - $19.88 $1.39 Million - $1.99 Million
-100,000 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$17.5 - $20.34 $1.75 Million - $2.03 Million
100,000 New
100,000 $1.97 Million

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.